BMY Other Income/Expenses (Net)

Bristol Myers Squibb · Other Income/Expenses (Net)

BMY logo

BMY Other Income/Expenses (Net)

Latest reported-$1.93B
BMY TTM Other Income/Expenses (Net) (-$1.47B → -$1.93B)
High-resolution chart · PNG

BMY other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-1,932,000,000
-3,994,000,000
-4,395,000,000
-3,387,000,000
-3,358,000,000
-1,762,000,000
-14,266,000,000
-14,160,000,000
-13,486,000,000
-13,123,000,000
245,000,000
639,000,000
571,000,000
-71,000,000
-1,391,000,000
-1,949,000,000
-1,921,000,000
-2,028,000,000
-350,000,000
-9,569,000,000
-8,792,000,000
-7,265,000,000
-9,048,000,000
-122,000,000
-1,447,000,000
-2,283,000,000
-935,000,000
-311,000,000
607,000,000
711,000,000
850,000,000
1,125,000,000
849,000,000
1,431,000,000
1,710,000,000
1,609,000,000
1,620,000,000
1,513,000,000
1,376,000,000
985,000,000
1,113,000,000
563,000,000
347,000,000
567,000,000
501,000,000
721,000,000
667,000,000
733,000,000
460,000,000
213,000,000
-40,000,000
-55,000,000
-1,903,000,000
-1,754,000,000
-1,589,000,000
-1,565,000,000
340,000,000
342,000,000
334,000,000
596,000,000
550,000,000
577,000,000
374,000,000
61,000,000
141,000,000
202,000,000
428,000,000
1,534,000,000
1,350,000,000
1,145,000,000
1,067,000,000
-573,000,000
-134,000,000
64,000,000
10,000,000
78,000,000
-141,000,000
-195,000,000
14,000,000
511,000,000
998,000,000
924,000,000
565,000,000
607,000,000
-65,000,000
-449,000,000
-46,000,000
-97,000,000
-105,000,000
268,000,000
-18,000,000
-307,000,000
-1,233,000,000
-1,356,000,000
-1,648,000,000
-4,780,000,000
-3,729,000,000
-3,577,000,000
-3,242,000,000
32,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.